XIST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.969400E-01
Normal-vs-Stage2
3.526200E-01
Normal-vs-Stage3
3.509800E-01
Normal-vs-Stage4
6.809600E-01
Stage1-vs-Stage2
4.544000E-01
Stage1-vs-Stage3
8.514400E-01
Stage1-vs-Stage4
6.696400E-01
Stage2-vs-Stage3
4.530600E-01
Stage2-vs-Stage4
3.634400E-01
Stage3-vs-Stage4
5.589000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.691400E-01
Normal-vs-AfricanAmerican
2.784800E-01
Normal-vs-Asian
3.613800E-01
Caucasian-vs-AfricanAmerican
4.557300E-03
Caucasian-vs-Asian
8.833000E-01
AfricanAmerican-vs-Asian
1.489620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.506600E-01
Normal-vs-Female
5.948600E-01
Male-vs-Female
1.62458935193399E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.871600E-01
Normal-vs-Age(41-60Yrs)
3.779800E-01
Normal-vs-Age(61-80Yrs)
3.537600E-01
Normal-vs-Age(81-100Yrs)
4.045200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.106200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.582400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.927800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.279400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.911600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.183200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.356600E-01
Normal-vs-Daily Drinker
3.296400E-01
Normal-vs-Weekly Drinker
3.924800E-01
Normal-vs-Occasional Drinker
3.714600E-01
Normal-vs-Social Drinker
4.586800E-01
Non Drinker-vs-Daily Drinker
8.885200E-01
Non Drinker-vs-Weekly Drinker
4.314600E-01
Non Drinker-vs-Occasional Drinker
6.015400E-01
Non Drinker-vs-Social Drinker
1.070420E-01
Daily Drinker-vs-Weekly Drinker
3.897400E-01
Daily Drinker-vs-Occasional Drinker
5.486600E-01
Daily Drinker-vs-Social Drinker
1.018620E-01
Weekly Drinker-vs-Occasional Drinker
8.286000E-01
Weekly Drinker-vs-Social Drinker
5.415400E-01
Occasional Drinker-vs-Social Drinker
3.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.658200E-01
Normal-vs-Grade 2
3.771800E-01
Normal-vs-Grade 3
5.093000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.863200E-01
Grade 1-vs-Grade 3
9.727200E-01
Grade 1-vs-Grade 4
4.658200E-01
Grade 2-vs-Grade 3
7.995600E-01
Grade 2-vs-Grade 4
3.771800E-01
Grade 3-vs-Grade 4
5.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.963200E-01
Normal-vs-NonDiabetic
3.736000E-01
Diabetic-vs-NonDiabetic
3.021000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.851200E-01
Normal-vs-NoPancreatitis
3.449000E-01
Pancreatitis-vs-NoPancreatitis
5.494400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.738800E-01
Normal-vs-N1
3.585400E-01
N0-vs-N1
7.155200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.041600E-01
Normal-vs-TP53-NonMutant
4.294200E-01
TP53-Mutant-vs-TP53-NonMutant
6.465400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
